Excerpts from the PFIC website:
Become more familiarized with the scientific facts regarding SARS-CoV-2 infection and COVID-19 vaccines: https://physiciansforinformedconsent.org/education/
Q&A: https://physiciansforinformedconsent.org/faq/
COVID-19 – WHAT YOU NEED TO KNOW -- https://physiciansforinformedconsent.org/covid-19-disease-information-statement/
A Stanford University systematic review that included 69 antibody studies estimated that the COVID-19 IFR in the United States ranges from 0.3% to 0.4%.8 Data analysis herein uses the midpoint of that range, 0.35%.
…people who receive the vaccine have a two-fold to six-fold increased risk of a severe adverse event compared to those who do not receive the vaccine.33,43,44
=====================================
COVID-19 VACCINE MANDATES: SCIENTIFIC FACTS THAT CHALLENGE THE ASSUMPTIONS
Excerpts from this article:
https://physiciansforinformedconsent.org/covid-19-vaccine-risk-statement/
A study of a COVID-19 outbreak in July 2021 published in Eurosurveillance observed that 100% of severe, critical, and fatal cases of COVID-19 occurred in vaccinated individuals.1
CDC data show mass vaccination with the COVID-19 vaccine has had no measurable impact on the COVID-19 mortality rate in the U.S. In the nine months before the introduction of mass vaccination (April 2020 through December 2020), there were about 356,000 COVID-19 deaths or 39,500 deaths per month — a mortality rate of 0.120 per 1,000 people.
In the nine months after the introduction of mass vaccination (January 2021 through September 2021), there were 342,000 COVID-19 deaths or 38,000 deaths per month — a mortality rate of 0.115 per 1,000 people.
And in the five months that followed (October 2021 through February 2022), there were an additional 249,000 COVID-19 deaths or 49,800 deaths per month — a mortality rate of 0.151 per 1,000 people.7
A study published in Vaccine8 found that in the Pfizer trial, the number of serious adverse events in vaccinated people was higher than the number of COVID-19 hospitalizations prevented. For every two (2) COVID-19 hospitalizations prevented in vaccinated people, there were ten (10) COVID-19 vaccine serious adverse events.
In the Pfizer clinical trial, there were zero [0] cases of severe COVID-19 in children who did not receive the vaccine.9,10
In contrast, for children 5 years or older, the Pfizer COVID-19 vaccine clinical trial found that the vaccine causes severe (grade 3) systemic reactions that include fever greater than 102.1° F; vomiting that requires IV hydration; diarrhea of six or more loose stools in 24 hours; and severe fatigue, severe headache, severe muscle pain, or severe joint pain that prevents daily activity.10-13
In the clinical trial, a range of 1 in 59 to 1 in 143 vaccinated children 5 to 11 years of age suffered severe systemic reactions within seven days of the second dose.
There were 3 to 8 cases of SEVERE systemic reactions observed in the VACCINATED group [children 5 to 11 yrs. of age]…10
In the clinical trial, 1 in 9 vaccinated adolescents 12 to 15 years of age suffered severe systemic reactions within seven days of receiving the second dose. There were 7 times more severe systemic reactions observed in the vaccinated group than non-severe COVID-19 cases in the unvaccinated group.11-13
The clinical trial also found that 1 in about 1,100 vaccinated children 12 to 15 years of age had a grade 4 systemic reaction (fever greater than 104° F) after the first dose that required an emergency room (ER) visit and withdrawal from the study.11,14
Safety surveillance reports have identified serious risks of myocarditis and pericarditis in subjects under age 40, within seven days of vaccination.
In males aged 18 to 24 years, a study published in Pharmacoepidemiology and Drug Safety observed a risk of myocarditis of 1 in 1,862 after the second dose of a COVID-19 mRNA vaccine.19
In addition, a study conducted by the Florida Department of Health found a 97% increased risk of cardiac-related deaths in males aged 18–39 within 28 days of being vaccinated with a COVID-19 vaccine.20
In women, a study published in BMJ found that vaccination with two doses within the same menstrual cycle led to a 3.7-day increase in that cycle…
Hundreds of studies have observed the effectiveness of various treatments, the most studied being ivermectin, vitamin D, hydroxychloroquine (HCQ), and monoclonal antibodies.30-33 These treatments may also be beneficial for prophylaxis (i.e., pre-exposure or post-exposure prevention of symptomatic COVID-19 infections).34-38
For people not living in a nursing home, the overall survival rate of COVID-19 is 99.8%, and 99.999% for children specifically.
These data suggest that there are 6 times more cases of COVID-19 in vaccinated subjects than in unvaccinated subjects previously infected with SARS-CoV-2.39
The Johnson & Johnson vaccine clinical trial found there are 6 times more cases of COVID-19 in vaccinated subjects than in unvaccinated subjects previously infected with SARS-CoV-2.
Infection and transmission of SARS-CoV-2 occur at high rates in fully vaccinated populations, and a significant proportion of severe, critical and fatal COVID-19 cases occur in fully vaccinated individuals.
CDC data show mass vaccination with the COVID-19 vaccine has had no measurable impact on COVID-19 mortality in the U.S.
##############
1.25.23
“What the Public Needs To Know About COVID-19”
From Physicians for Informed Consent
Excerpts from the PFIC website:
Become more familiarized with the scientific facts regarding SARS-CoV-2 infection and COVID-19 vaccines: https://physiciansforinformedconsent.org/education/
Q&A: https://physiciansforinformedconsent.org/faq/
COVID-19 – WHAT YOU NEED TO KNOW -- https://physiciansforinformedconsent.org/covid-19-disease-information-statement/
A Stanford University systematic review that included 69 antibody studies estimated that the COVID-19 IFR in the United States ranges from 0.3% to 0.4%.8 Data analysis herein uses the midpoint of that range, 0.35%.
…people who receive the vaccine have a two-fold to six-fold increased risk of a severe adverse event compared to those who do not receive the vaccine.33,43,44
=====================================
COVID-19 VACCINE MANDATES: SCIENTIFIC FACTS THAT CHALLENGE THE ASSUMPTIONS
Excerpts from this article:
https://physiciansforinformedconsent.org/covid-19-vaccine-risk-statement/
A study of a COVID-19 outbreak in July 2021 published in Eurosurveillance observed that 100% of severe, critical, and fatal cases of COVID-19 occurred in vaccinated individuals.1
CDC data show mass vaccination with the COVID-19 vaccine has had no measurable impact on the COVID-19 mortality rate in the U.S. In the nine months before the introduction of mass vaccination (April 2020 through December 2020), there were about 356,000 COVID-19 deaths or 39,500 deaths per month — a mortality rate of 0.120 per 1,000 people.
In the nine months after the introduction of mass vaccination (January 2021 through September 2021), there were 342,000 COVID-19 deaths or 38,000 deaths per month — a mortality rate of 0.115 per 1,000 people.
And in the five months that followed (October 2021 through February 2022), there were an additional 249,000 COVID-19 deaths or 49,800 deaths per month — a mortality rate of 0.151 per 1,000 people.7
A study published in Vaccine8 found that in the Pfizer trial, the number of serious adverse events in vaccinated people was higher than the number of COVID-19 hospitalizations prevented. For every two (2) COVID-19 hospitalizations prevented in vaccinated people, there were ten (10) COVID-19 vaccine serious adverse events.
In the Pfizer clinical trial, there were zero [0] cases of severe COVID-19 in children who did not receive the vaccine.9,10
In contrast, for children 5 years or older, the Pfizer COVID-19 vaccine clinical trial found that the vaccine causes severe (grade 3) systemic reactions that include fever greater than 102.1° F; vomiting that requires IV hydration; diarrhea of six or more loose stools in 24 hours; and severe fatigue, severe headache, severe muscle pain, or severe joint pain that prevents daily activity.10-13
In the clinical trial, a range of 1 in 59 to 1 in 143 vaccinated children 5 to 11 years of age suffered severe systemic reactions within seven days of the second dose.
There were 3 to 8 cases of SEVERE systemic reactions observed in the VACCINATED group [children 5 to 11 yrs. of age]…10
In the clinical trial, 1 in 9 vaccinated adolescents 12 to 15 years of age suffered severe systemic reactions within seven days of receiving the second dose. There were 7 times more severe systemic reactions observed in the vaccinated group than non-severe COVID-19 cases in the unvaccinated group.11-13
The clinical trial also found that 1 in about 1,100 vaccinated children 12 to 15 years of age had a grade 4 systemic reaction (fever greater than 104° F) after the first dose that required an emergency room (ER) visit and withdrawal from the study.11,14
Safety surveillance reports have identified serious risks of myocarditis and pericarditis in subjects under age 40, within seven days of vaccination.
In males aged 18 to 24 years, a study published in Pharmacoepidemiology and Drug Safety observed a risk of myocarditis of 1 in 1,862 after the second dose of a COVID-19 mRNA vaccine.19
In addition, a study conducted by the Florida Department of Health found a 97% increased risk of cardiac-related deaths in males aged 18–39 within 28 days of being vaccinated with a COVID-19 vaccine.20
In women, a study published in BMJ found that vaccination with two doses within the same menstrual cycle led to a 3.7-day increase in that cycle…
Hundreds of studies have observed the effectiveness of various treatments, the most studied being ivermectin, vitamin D, hydroxychloroquine (HCQ), and monoclonal antibodies.30-33 These treatments may also be beneficial for prophylaxis (i.e., pre-exposure or post-exposure prevention of symptomatic COVID-19 infections).34-38
For people not living in a nursing home, the overall survival rate of COVID-19 is 99.8%, and 99.999% for children specifically.
These data suggest that there are 6 times more cases of COVID-19 in vaccinated subjects than in unvaccinated subjects previously infected with SARS-CoV-2.39
The Johnson & Johnson vaccine clinical trial found there are 6 times more cases of COVID-19 in vaccinated subjects than in unvaccinated subjects previously infected with SARS-CoV-2.
Infection and transmission of SARS-CoV-2 occur at high rates in fully vaccinated populations, and a significant proportion of severe, critical and fatal COVID-19 cases occur in fully vaccinated individuals.
CDC data show mass vaccination with the COVID-19 vaccine has had no measurable impact on COVID-19 mortality in the U.S.
##############